Company / Free Cash Flow per Share
ANI Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$8.12
FY2025
5-year range
-$2.46 / $8.12
FY2021-FY2025
Trend
+176.3%
vs FY2024
Sector context
#11 of 192
Health Care
What the data says
Among 192 Health Care companies, ANI Pharmaceuticals, Inc. is in the top 6% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-2.46 in FY2022 to $8.12 in FY2025.
Based on SEC 10-K filings.
8.12 in FY2025 with a 5-year CAGR of +60.5%. Top quartile in the Health Care sector.
Improved from $6.05 to $8.12 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +60.5%
- 10-Year CAGR
- -
Sector benchmark
+140.9% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 176.3% year-over-year.
- Ranks #11 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.12 | +176.3% |
| FY2024 | $2.94 | -51.4% |
| FY2023 | $6.05 | +345.5% |
| FY2022 | -$2.46 | -4158.5% |
| FY2021 | $0.06 | -92.0% |
| FY2020 | $0.76 | -77.4% |
| FY2019 | $3.38 | -35.2% |
| FY2018 | $5.21 | +107.3% |
| FY2017 | $2.51 | +27.0% |
| FY2016 | $1.98 | +100.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026